Concord Drugs Market Cap

Concord Drugs has a market cap or net worth of 620.50 million as of August 29, 2025. Its market cap has increased by 77.79% in one year.

Market Cap

620.50M

Enterprise Value

810.68M

Revenue

471.58M

Ranking

n/a

PE Ratio

146.40

Stock Price

62.05

Market Cap Chart

Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 620.50M, an increase of 328.51%. That is a compound annual growth rate of 14.83%.

Market Cap History

Date	Market Cap	% Change
Aug 29, 2025	620.50M	64.59%
Dec 31, 2024	377.00M	-36.87%
Dec 29, 2023	597.20M	109.83%
Dec 30, 2022	284.61M	1.24%
Dec 31, 2021	281.11M	40.39%
Dec 31, 2020	200.23M	69.79%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	18.37T
HDFC Bank	14.61T
Bharti Airtel	11.33T
Tata Consultancy Services	11.16T
ICICI Bank	9,981.58B
State Bank of India	7,407.57B
Hindustan Unilever	6,249.44B
Infosys	6,091.89B

Market Cap Rankings